- Home
- HCAC vs RLMD Comparison
HCAC vs RLMD Comparison
Compare HCAC & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCAC | RLMD |
|---|---|---|
| Founded | 2025 | 2004 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 294.9M | 348.8M |
| IPO Year | 2025 | 2012 |
Fundamental Metrics
Financial Performance| Metric | HCAC | RLMD |
|---|---|---|
| Price | $10.13 | $3.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | 104.4K | ★ 1.5M |
| Earning Date | 01-01-0001 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.28 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,070.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 154.83 |
| 52 Week Low | $9.92 | $2.15 |
| 52 Week High | $10.18 | $8.00 |
Technical Indicators
Market Signals| Indicator | HCAC | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.23 | 41.78 |
| Support Level | $10.05 | $3.13 |
| Resistance Level | $10.18 | $3.55 |
| Average True Range (ATR) | 0.01 | 0.20 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 18.18 | 46.86 |
Price Performance
Historical ComparisonAbout HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares
Hall Chadwick Acquisition Corp is a blank check company.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.